BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21571)

  • 21. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
    Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulpiride in tardive dyskinesia.
    Casey DE; Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of outcome in first-episode schizophrenia.
    Lieberman JA
    J Clin Psychiatry; 1993 Mar; 54 Suppl():13-7. PubMed ID: 8097192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amisulpride-induced tardive dystonia: a case report.
    Guriz O; Ekinci AE; Orsel S; Ekinci O
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):412-3. PubMed ID: 19944732
    [No Abstract]   [Full Text] [Related]  

  • 26. Gynecomastia with sulpiride.
    Kaneda Y; Fujii A
    J Clin Pharm Ther; 2002 Feb; 27(1):75-7. PubMed ID: 11846864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amisulpride--an open clinical study of a new benzamide in schizophrenic patients.
    Mann K; Bartels M; Bauer H; Gaertner HJ
    Pharmacopsychiatry; 1984 Jul; 17(4):111-5. PubMed ID: 6147865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
    Elizur A; Segal S; Yeret A; Ben-David M
    Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sulpiride: a neuroleptic agent of new generation with unique pharmacological qualities and rather wide range of clinical applications].
    Pawłowski L
    Psychiatr Pol; 1993; 27(2):199-205. PubMed ID: 8104350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine tests during treatment with neuroleptic drugs. III. Plasma growth hormone and prolactin responses to apomorphine.
    Kolakowska T; Gelder M; Fraser S
    Br J Psychiatry; 1981 Nov; 139():408-12. PubMed ID: 6120733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia induced by sulpiride.
    Achiron A; Zoldan Y; Melamed E
    Clin Neuropharmacol; 1990 Jun; 13(3):248-52. PubMed ID: 2357706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-over comparison of the therapeutic effects of sulpiride and perphenazine in schizophrenic and schizoaffective psychoses.
    Svestka J; Rysánek R; Cesková E; Náhunek K
    Act Nerv Super (Praha); 1989 Apr; 31(1):35-6. PubMed ID: 2571220
    [No Abstract]   [Full Text] [Related]  

  • 33. Naloxone in chronic schizophrenic patients: neuroendocrine and behavioral effects.
    Kleinman JE; Weinberger DR; Rogol A; Shiling DJ; Mendelson WB; Davis GC; Bunney WE; Wyatt RJ
    Psychiatry Res; 1982 Aug; 7(1):1-7. PubMed ID: 6127744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulpiride in tardive dyskinesia.
    Gerlach J; Casey DE
    Acta Psychiatr Scand Suppl; 1984; 311():93-102. PubMed ID: 6142590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical-neuroleptic investigation of N-((1-ethyl-pyrrolidine-2-yl)-methyl)-2-methoxy-5-sulfamyl-benzamide-neuroleptic sulpiride (Dogmatil) in acutly ill schizophrenics].
    Haase HJ; Floru L; Ulrich F
    Int Pharmacopsychiatry; 1974; 9(2):77-94. PubMed ID: 4603413
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolactin levels and effects of neuroleptics.
    Brown WA
    Psychosomatics; 1983 Jun; 24(6):569-74, 577-81. PubMed ID: 6136065
    [No Abstract]   [Full Text] [Related]  

  • 37. A neuroendocrine study of supersensitivity in tardive dyskinesia.
    Tamminga CA; Smith RC; Pandey G; Frohman LA; Davis JM
    Arch Gen Psychiatry; 1977 Oct; 34(10):1199-203. PubMed ID: 911219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment.
    Christie JE; Whalley LJ; Hunter R; Bennie J; Fink G
    J Affect Disord; 1989; 16(2-3):115-20. PubMed ID: 2522110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
    Ringwald E; Lustig A; Moscovici M; Spiegel R; Vamos E
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):318-24. PubMed ID: 6111093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia.
    Peitl MV; Pavlović E; Peitl A; Peitl V
    Psychiatr Danub; 2010 Mar; 22(1):123-4. PubMed ID: 20305607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.